TopNews United Kingdom (blog)

<img alt="" height="1" width="1" />
FDA approves Amgen osteoporosis drug
NEW YORK, June 1 (Reuters) - The US Food and Drug Administration on Tuesday approved the sale of Amgen Inc&#39;s (AMGN.O) osteoporosis drug Prolia to help prevent fractures in postmenopausal women just days after the medicine received European approval. ...
Amgen&#39;s Bone Drug Cleared by US for OsteoporosisBusinessWeek
FDA Clears Amgen&#39;s Bone-Strengthening Drug ProliaNPR
Amgen ready to extend global reachFinancial Times
FierceBiotech -PR Newswire (press release)
all 58 news articles &raquo;